AIM
CSII

Acrospire Investment Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Acrospire Investment Management’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,271
Closed -$41K – 1602
2017
Q2 		$41K Sell
1,271
-3,000
-70% -$91.4K 0.04% 1054
2017
Q1 		$121K Hold
4,271
– – 0.1% 215
2016
Q4 		$103K Buy
4,271
+3,265
+325% +$80.1K 0.04% 908
2016
Q3 		$24K Buy
+1,006
New +$22K 0.02% 1442

Other funds holding CSII

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Acrospire Investment Management's CSII Position: Q3 2017 in Review

Acrospire Investment Management sold out of Cardiovascular Systems, Inc. (CSII) in Q3 2017, closing a stake of 1,271 shares — an estimated $41K sold.

Acrospire Investment Management first reported a position in CSII in Q3 2016 and held it in 4 quarters. The position peaked at $121K in Q1 2017. 142 funds tracked by Wall St. Rank hold CSII as of Q3 2017.

  • Acrospire Investment Management reported no remaining Cardiovascular Systems, Inc. position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,271 Cardiovascular Systems, Inc. shares in Q3 2017, an estimated $41K.
  • Acrospire Investment Management first reported a position in Cardiovascular Systems, Inc. in Q3 2016 and held it in 4 quarters.
  • Acrospire Investment Management's Cardiovascular Systems, Inc. position peaked at $121K in Q1 2017.
  • 142 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.